110 Results

People

  1. Ragupathi
    Ragupathi
  2. Livingston
    Livingston
  3. Danishefsky
    Danishefsky
  4. Wolchok
    Wolchok
  5. Rosen
    Rosen
  6. Merghoub
    Merghoub
  7. Chapman
    Chapman
  8. Solit
    Solit
  9. Spassova
    Spassova
  10. Scher
    Scher

Groups

  1. Department of Medicine (110)
  2. Melanoma and Immunotherapeutics Service (110)
  3. Molecular Pharmacology and Chemistry Program Faculty (110)
  4. Sloan Kettering Institute Faculty (110)
  5. Solid Tumor Oncology Division (110)
  6. GSK Faculty (63)
  7. Melanoma Disease Management Team (60)
  8. Genitourinary Oncology Service (44)
  9. Hematologic Malignancies, Division of (38)
  10. Sloan Kettering Institute Postdocs (35)
  1. "Molecular Pharmacology and Chemistry Program Faculty"
  2. "Melanoma and Immunotherapeutics Service"
Formats
  1. Journal Article (69)
  2. Meeting Abstract (40)
  3. Book Section (1)
Groups
  1. Department of Medicine (110)
  2. Melanoma and Immunotherapeutics Service (110)
  3. Molecular Pharmacology and Chemistry Program Faculty (110)
  4. Sloan Kettering Institute Faculty (110)
  5. Solid Tumor Oncology Division (110)
  6. GSK Faculty (63)

More Groups

People
  1. Govindaswami Ragupathi (51)
  2. Philip Livingston (45)
  3. Samuel Danishefsky (44)
  4. Jedd Wolchok (33)
  5. Neal Rosen (29)
  6. Paul Chapman (25)

More People

Years
  1. 2023 (3)
  2. 2022 (6)
  3. 2021 (4)
  4. 2020 (4)
  5. 2019 (3)
  6. 2017 (2)

More Years

Publications
  1. Cancer Research (16)
  2. Proceedings of the American Association for Cancer Research Annual Meeting (11)
  3. Clinical Cancer Research (9)
  4. Journal of the American Chemical Society (6)
  5. Cancer Immunology, Immunotherapy (5)
  6. Nature (5)

More Publications

Publishers
  1. American Association for Cancer Research (39)
  2. American Chemical Society (10)
  3. Nature Publishing Group (7)
  4. Elsevier Inc. (6)
  5. American Society of Clinical Oncology (5)
  6. National Academy of Sciences (5)

More Publishers

Results (110)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of tumor metabolism on the microenvironment and response to immunotherapy
    Meeting Abstract

    Zappasodi, R.; Serganova, I.; Brunschvig, S.; Santhella, A.; Mane, M.; Vemuri, K.; Ijoma, J.; Kang, W.; Manovatodorova, K.; Koutcher, J.; more...
    Cancer Science (2023)

    Fulltext@MSK | Save
  • Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
    Journal Article

    Rojas, L. A.; Sethna, Z.; Soares, K. C.; Olcese, C.; Pang, N.; Patterson, E.; Lihm, J.; Ceglia, N.; Guasp, P.; Chu, A.; more...
    Nature (2023)

    Fulltext@MSK | Save
  • The ectonucleotidase CD39 identifies tumor-reactive CD8(+) T cells predictive of immune checkpoint blockade efficacy in human lung cancer
    Journal Article

    Chow, A.; Uddin, F. Z.; Liu, M.; Dobrin, A.; Nabet, B. Y.; Mangarin, L.; Lavin, Y.; Rizvi, H.; Tischfield, S. E.; Quintanal-Villalonga, A.; more...
    Immunity (2023)

    Fulltext@MSK | Save
  • LDH inhibition improves response to CTLA-4 blockade by enhancing effector T cell activity and impairing regulatory T cell suppression
    Meeting Abstract

    Verma, S.; Serganova, I.; Budhu, S.; Dong, L.; Mangarin, L.; Ko, M.; Blasberg, R.; Zappasodi, R.; Wolchok, J.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Combining a novel MEK inhibitor with immunomodulation to promote an anti-tumor response
    Meeting Abstract

    Dong, L.; Choi, H.; Budhu, S.; Schulze, I.; Verma, S.; Mehanna, N.; Rosen, N.; Merghoub, T.; Wolchok, J.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Deferiprone alters macrophage function and metabolism
    Meeting Abstract

    Ackerstaff, E.; Budhu, S.; Winkleman, D. P.; Min, S. S.; Ijoma, J. N.; Serganova, I. S.; Blasberg, R. G.; Merghoub, T.; Koutcher, J. A.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Clinicopathologic characterization of ERK2 E322K mutation in solid tumors: Implications for treatment and drug development
    Meeting Abstract

    Liu, D.; Murciano-Goroff, Y. R.; Jee, J.; Arcila, M. E.; Buonocore, D. J.; Gao, J.; Chakravarty, D.; Schram, A. M.; Callahan, M. K.; Friedman, C. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Neoantigen quality predicts immunoediting in survivors of pancreatic cancer
    Journal Article

    Łuksza, M.; Sethna, Z. M.; Rojas, L. A.; Lihm, J.; Bravi, B.; Elhanati, Y.; Soares, K.; Amisaki, M.; Dobrin, A.; Hoyos, D.; more...
    Nature (2022)

    Fulltext@MSK | Save
  • Anatomic position determines oncogenic specificity in melanoma
    Journal Article

    Weiss, J. M.; Hunter, M. V.; Cruz, N. M.; Baggiolini, A.; Tagore, M.; Ma, Y.; Misale, S.; Marasco, M.; Simon-Vermot, T.; Campbell, N. R.; more...
    Nature (2022)

    Fulltext@MSK | Save
  • Combining a novel dual RAF/MEK inhibitor with immunomodulation to promote an anti-tumor response
    Meeting Abstract

    Dong, L.; Choi, H.; Budhu, S.; Schulze, I.; Mehanna, N.; Rosen, N.; Merghoub, T.; Wolchok, J.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save